Study points to practice-changing care for patients with refractory metastatic colorectal cancer

by Vall d'Hebron Institute of OncologyCredit: Unsplash/CC0 Public DomainJosep Tabernero, Director of the Vall d'Hebron Institute of Oncology (VHIO), presented data from the international phase

Updated on: February 23,2024

Study points to practice-changing care for patients with refractory metastatic colorectal cancer

by Vall d'Hebron Institute of OncologyCredit: Unsplash/CC0 Public DomainJosep Tabernero, Director of the Vall d'Hebron Institute of Oncology (VHIO), presented data from the international phase

Updated on:February 23,2024

Liquid biopsy has prognostic role in colorectal cancer and potential for guiding therapy

by European Society for Medical OncologyCredit: European Society for Medical OncologyLiquid biopsy is likely to play an increasing role in identifying patients with colorectal cancer (CRC) who ar

Updated on: May 23,2024

Liquid biopsy has prognostic role in colorectal cancer and potential for guiding therapy

by European Society for Medical OncologyCredit: European Society for Medical OncologyLiquid biopsy is likely to play an increasing role in identifying patients with colorectal cancer (CRC) who ar

Updated on:May 23,2024

One simple change cut unnecessary imaging for cancer patients in half

by Perelman School of Medicine at the University of PennsylvaniaKiller T cells surround a cancer cell. Credit: NIHSimply introducing a default physician order—a "nudge"—into electronic

Updated on: May 23,2024

One simple change cut unnecessary imaging for cancer patients in half

by Perelman School of Medicine at the University of PennsylvaniaKiller T cells surround a cancer cell. Credit: NIHSimply introducing a default physician order—a "nudge"—into electronic

Updated on:May 23,2024

Study: Biomarker in urine may offer noninvasive detection of prostate cancer

by Henry Ford Health SystemNallasivam Palanisamy, Ph.D., associate scientist in the Vattikuti Urology Institute at Henry Ford Health System, examines prostate cancer cells. Credit: Henry Ford Hea

Updated on: March 01,2024

Study: Biomarker in urine may offer noninvasive detection of prostate cancer

by Henry Ford Health SystemNallasivam Palanisamy, Ph.D., associate scientist in the Vattikuti Urology Institute at Henry Ford Health System, examines prostate cancer cells. Credit: Henry Ford Hea

Updated on:March 01,2024

Enzyme that helps protect us from stress linked to liver cancer growth

by Medical College of Georgia at Augusta UniversityDr. Satya Ande, molecular biologist in the MCG Department of Biochemistry and Molecular Biology and Georgia Cancer Center and MCG postdoctoral f

Updated on: April 14,2024

Enzyme that helps protect us from stress linked to liver cancer growth

by Medical College of Georgia at Augusta UniversityDr. Satya Ande, molecular biologist in the MCG Department of Biochemistry and Molecular Biology and Georgia Cancer Center and MCG postdoctoral f

Updated on:April 14,2024

In the lab and in the clinic, alisertib with TAK-228 excels against solid tumors

by CU Anschutz Medical CampusUniversity of Colorado Cancer Center investigator, Jennifer Diamond, MD, and colleagues report promising phase I results of alisertib with TAK-228 against solid tumor

Updated on: April 22,2024

In the lab and in the clinic, alisertib with TAK-228 excels against solid tumors

by CU Anschutz Medical CampusUniversity of Colorado Cancer Center investigator, Jennifer Diamond, MD, and colleagues report promising phase I results of alisertib with TAK-228 against solid tumor

Updated on:April 22,2024

Increasing the dose intensity of chemotherapy reduces the risk of breast cancer recurrence and death

by Medical Research CouncilCredit: PixabayGiving chemotherapy drugs every two weeks instead of the usual every three weeks reduces the risk of breast cancer recurrence and death, according to new

Updated on: March 08,2024

Increasing the dose intensity of chemotherapy reduces the risk of breast cancer recurrence and death

by Medical Research CouncilCredit: PixabayGiving chemotherapy drugs every two weeks instead of the usual every three weeks reduces the risk of breast cancer recurrence and death, according to new

Updated on:March 08,2024

Blocking DNA production in cancer therapy by targeting the POLtheta enzyme

by Austrian Academy of SciencesGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111716BRCA1 (BReast CAncer Gene 1), a key gene that becomes faulty in some instance

Updated on: January 07,2024

Blocking DNA production in cancer therapy by targeting the POLtheta enzyme

by Austrian Academy of SciencesGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111716BRCA1 (BReast CAncer Gene 1), a key gene that becomes faulty in some instance

Updated on:January 07,2024

Researchers discover how bacteria make pancreatic cancer cells grow and move

by Virginia TechPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteVirginia Tech researchers from the Department of Biomedical Enginee

Updated on: January 30,2024

Researchers discover how bacteria make pancreatic cancer cells grow and move

by Virginia TechPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteVirginia Tech researchers from the Department of Biomedical Enginee

Updated on:January 30,2024

Combination drug activates calcium channels to trigger deadly influx of calcium ions inside tumor cells

JANUARY 29, 2024byWileyCredit:Angewandte Chemie International Edition(2024). DOI: 10.1002/anie.202317578Calcium ions are essential for cells, but can be toxic in higher concentration

Updated on: March 25,2024

Combination drug activates calcium channels to trigger deadly influx of calcium ions inside tumor cells

JANUARY 29, 2024byWileyCredit:Angewandte Chemie International Edition(2024). DOI: 10.1002/anie.202317578Calcium ions are essential for cells, but can be toxic in higher concentration

Updated on:March 25,2024

Treatment of aggressive breast cancer: Discovery of a new protein involved in the development of metastases

JANUARY 31, 2024byCNRSIllustration of the invasive capacity of breast cancer cells with (on) and without (off) SMYD2 expression; Scale bar: 10µm. Credit: Casanova et al.A protein found abundantl

Updated on: March 25,2024

Treatment of aggressive breast cancer: Discovery of a new protein involved in the development of metastases

JANUARY 31, 2024byCNRSIllustration of the invasive capacity of breast cancer cells with (on) and without (off) SMYD2 expression; Scale bar: 10µm. Credit: Casanova et al.A protein found abundantl

Updated on:March 25,2024

Stopping cancer from recruiting immune system double agents

by Rush University Medical CenterCredit: Rush University Medical CenterCancerous tumors trick myeloid cells, an important part of the immune system, into perceiving them as a damaged part of the

Updated on: April 01,2024

Stopping cancer from recruiting immune system double agents

by Rush University Medical CenterCredit: Rush University Medical CenterCancerous tumors trick myeloid cells, an important part of the immune system, into perceiving them as a damaged part of the

Updated on:April 01,2024